Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
NCT04754087 · View on ClinicalTrials.gov ↗
Study Summary
The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
Conditions Studied
Interventions
- DEVICE Vivacit-E and Longevity (HXLPE) Liners
Study Locations (11)
Other
- Copenhagen University Hospital Hvidovre — Hvidovre
- Zuyderland Hospital — Geleen
- OCON Hengelo — Hengelo
- Skane University Hospital — Lund
Oregon
- Slocum Center for Orthopedics & Sports Medicine — Eugene
- Oregon Health and Science University — Portland
Colorado
- Colorado Joint Replacement — Denver
Indiana
- South Bend Orthopaedics — South Bend
North Carolina
- Duke University Medical Center — Durham
Utah
- University of Utah Health — Salt Lake City
UK
- The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Royal Bournemouth Hospital — Bournemouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-07-07 |
| Est. Completion | 2033-12-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04754087
The ClinicalTrials.gov registry entry for NCT04754087 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 102 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 8 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention — of which Vivacit-E and Longevity (HXLPE) Liners is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04754087 reports 11 study locations spanning 7 distinct geographic areas — top geographies include Other, Oregon, Colorado. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04754087 about?
NCT04754087 is a clinical study titled "G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study". The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
What is the current status of trial NCT04754087?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-07-07. Estimated completion is 2033-12-31.
What conditions does trial NCT04754087 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Total Hip Arthroplasty, Avascular Necrosis of Hip, Degenerative Joint Disease of Hip, Rheumatoid Arthritis of Hip. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT04754087?
The interventions under investigation include: Vivacit-E and Longevity (HXLPE) Liners (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT04754087?
This trial is sponsored by Zimmer Biomet, which has 102 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04754087 being conducted?
This trial has 11 study locations across Colorado, Indiana, North Carolina, Oregon, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.